Olaratumab (Lartruvo™) is a recombinant human IgG1 monoclonal antibody that specifically binds PDGFRα. In order to support use of Lartruvo in pediatric patients, a definitive juvenile animal study in neonatal… Click to show full abstract
Olaratumab (Lartruvo™) is a recombinant human IgG1 monoclonal antibody that specifically binds PDGFRα. In order to support use of Lartruvo in pediatric patients, a definitive juvenile animal study in neonatal mice was conducted with a human anti‐mouse PDGFRα antibody analog of olaratumab (LSN3338786).
Keywords:
pdgfr monoclonal;
monoclonal antibody;
antibody assessment;
mice;
juvenile;
antibody
Journal Title: Birth Defects Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Birth Defects Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!